Arkin Bio Ventures is a Tel Aviv, Israel based venture capital firm founded in 2016. It is a part of Arkin Holdings.
The firm prefers to invest and support early and mid-stage companies that focus on immunotherapy, cancer, metabolism, microbiome, autoimmune diseases, and drug delivery platforms.
The notable investment portfolio of Arkin Bio Ventures includes ARTSaVIT, Keros Therapeutics, Metabomed, Oncorus, Pi Therapeutics, Werewolf Therapeutics. As of January 2020, Arkin Bio Ventures has made 10 investments.
Timeline
Invested in
Funding Rounds Participated In
People
Name
Role
LinkedIn
Pini Orbach Ph.D
Manager
Further reading
Title
Author
Link
Type
Date
Documentaries, videos and podcasts
Title
Date
Link
Companies
Company
CEO
Location
Products/Services
ARTSaVIT
Keros Therapeutics
Metabomed
Oncorus
Pi Therapeutics
Page 1 of 2
References
Venture capital firm
CompanyCompany attributes
Venture capital
Biotechnology
Autoimmune diseaseLocation
Tel AvivCompany status
Active
Crunchbase
Pitchbook
Founded date
2016
Categories
Related Topics
Contributors
- 1
Lax Mariappan
Technopreneur, Open source enthusiast, author, speaker. Co-founder of Eternus Global. Crafting applications for the medical industry. - 2
Jed Christiansen
Director of Product and Data at Golden || Founder - Seed-DB. - 3
Neelam Jhaveri
Techno Geek + Gamer + Fashionista + Sense of Humor = It's ME - 4
Aime Anne Nisay
QA Engineer of web and mobile applications - 5
Henry Ogolla
Passionate about reading and writing. - 6
Rachel Phythian
Advisor / Investor